Literature DB >> 1883986

Stages of recovery during post-traumatic amnesia and subsequent everyday memory deficits.

G M Geffen1, J S Encel, G M Forrester.   

Abstract

Post-traumatic amnesia (PTA) is the period following brain trauma when patients are unable to acquire and retain information. Nineteen patients with brain injury were assessed for PTA, with a new scale, after they regained consciousness, every 24 h. Patients recovered orientation and their capacity to recognise new information, and finally their ability to recall this information. The longer the duration of PTA, the poorer was performance on an everyday memory test given one month after recovery from PTA. Patients with orthopaedic injuries and without brain injury showed minimal impairment on the PTA scale. The predictive value of the scale (multiple R = 0.88) with respect to subsequent everyday memory performance indicates its usefulness as an index of severity of brain injury.

Entities:  

Mesh:

Year:  1991        PMID: 1883986     DOI: 10.1097/00001756-199102000-00010

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

Review 1.  Neuropsychological evaluation of everyday memory.

Authors:  M Perez Garcia; J F Godoy Garcia; N Vera Guerrero; J A Laserna Triguero; A E Puente
Journal:  Neuropsychol Rev       Date:  1998-12       Impact factor: 7.444

2.  Resolution of disorientation and amnesia during post-traumatic amnesia.

Authors:  R L Tate; A Pfaff; L Jurjevic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

3.  Posttraumatic Retrograde and Anterograde Amnesia: Pathophysiology and Implications in Grading and Safe Return to Play.

Authors:  Robert C. Cantu
Journal:  J Athl Train       Date:  2001-09       Impact factor: 2.860

4.  Relationship between post-traumatic amnesia and white matter integrity in traumatic brain injury using tract-based spatial statistics.

Authors:  Min Jye Cho; Sung Ho Jang
Journal:  Sci Rep       Date:  2021-03-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.